Dr. Bhavya Doshi, M.D.
Pediatric Hematology & Oncology (Pediatric Hematology & Oncology Physician)
Emory Children's Center 2015 Uppergate Dr Ne Room 440
Atlanta, GA 30322
At a glance
- In the NPI registry since
- 2012
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2012Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pediatric Hematology & Oncology Physician primary
GA license 102724 · PA license MD454435
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Payments from drug and device companies
In 2025, 2 companies reported 14 payments worth $22,225 in total to this clinician.
| Genzyme Corporation | $11,316 |
|---|---|
| Csl Behring | $10,910 |
| Travel and Lodging | $11,728 |
|---|---|
| Consulting Fee | $10,101 |
| Food and Beverage | $397 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Genzyme Corporation Nov 7, 2025 | Consulting Fee QFITLIA | $10,101 |
| Csl Behring Oct 5, 2025 | Travel and Lodging travel to SEVILLE, Spain · in-kind | $9,691 |
| Csl Behring Oct 7, 2025 | Travel and Lodging travel to SEVILLE, Spain · in-kind | $708 |
| Genzyme Corporation Nov 7, 2025 | Travel and Lodging QFITLIA · travel to Dallas, TX · in-kind | $409 |
| Genzyme Corporation Nov 7, 2025 | Travel and Lodging QFITLIA · travel to Dallas, TX · in-kind | $297 |
| Genzyme Corporation Nov 7, 2025 | Travel and Lodging QFITLIA · travel to Dallas, TX · in-kind | $246 |
| Csl Behring Oct 5, 2025 | Travel and Lodging travel to SEVILLE, Spain · in-kind | $194 |
| Csl Behring Oct 7, 2025 | Travel and Lodging travel to SEVILLE, Spain · in-kind | $149 |
| Genzyme Corporation Nov 7, 2025 | Travel and Lodging QFITLIA · travel to Dallas, TX | $33.49 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $56,869 in research payments for these studies, mostly to the institutions running them.
- A Trial That Evaluates Disease Characteristics in Hemophilia B Adult Male Participants Receiving Prophylaxis With Standard of Care Factor IX Protein (FIX) Replacement Therapy
Regeneron Pharmaceuticals, Inc. · Active, not recruiting · NCT05568459
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.